MIG
ATYR

Mariner Investment Group’s aTyr Pharma ATYR Stock Holding History

Mariner Investment Group’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-3,619
Closed -$938K – 240
2015
Q2 		$938K Buy
+3,619
New +$1.12M 0.24% 112

Other funds holding ATYR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RCM
Riverhead Capital Management Wilmington, Delaware $2.71B AUM 2.34% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Mariner Investment Group's ATYR Position: Q3 2015 in Review

Mariner Investment Group sold out of aTyr Pharma (ATYR) in Q3 2015, closing a stake of 3,619 shares — an estimated $938K sold.

Mariner Investment Group first reported a position in ATYR in Q2 2015 and held it in 1 quarter. The position peaked at $938K in Q2 2015. 50 funds tracked by Wall St. Rank hold ATYR as of Q3 2015.

  • Mariner Investment Group reported no remaining aTyr Pharma position as of Q3 2015 after selling out during the quarter.
  • Mariner Investment Group sold 3,619 aTyr Pharma shares in Q3 2015, an estimated $938K.
  • Mariner Investment Group first reported a position in aTyr Pharma in Q2 2015 and held it in 1 quarter.
  • Mariner Investment Group's aTyr Pharma position peaked at $938K in Q2 2015.
  • 50 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2015.

Based on Mariner Investment Group's 13F filing for Q3 2015, filed 6 Nov 2015.